{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "COVID-19",
      "HCV",
      "HIV",
      "repurposed drugs",
      "treatment efficacy"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "33777024",
  "DateCompleted": {
    "Year": "2021",
    "Month": "04",
    "Day": "09"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "12",
    "Day": "07"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "03",
        "Day": "11"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "635371",
      "10.3389/fimmu.2021.635371"
    ],
    "Journal": {
      "ISSN": "1664-3224",
      "JournalIssue": {
        "Volume": "12",
        "PubDate": {
          "Year": "2021"
        }
      },
      "Title": "Frontiers in immunology",
      "ISOAbbreviation": "Front Immunol"
    },
    "ArticleTitle": "Lack of Effectiveness of Repurposed Drugs for COVID-19 Treatment.",
    "Pagination": {
      "StartPage": "635371",
      "MedlinePgn": "635371"
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "IrsiCaixa, Hospital Universitari Germans Trias i Pujol, Universitat Aut\u00f2noma de Barcelona, Badalona, Spain."
          }
        ],
        "LastName": "Martinez",
        "ForeName": "Miguel Angel",
        "Initials": "MA"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Switzerland",
    "MedlineTA": "Front Immunol",
    "NlmUniqueID": "101560960",
    "ISSNLinking": "1664-3224"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antiviral Agents"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "adverse effects",
        "therapeutic use"
      ],
      "DescriptorName": "Antiviral Agents"
    },
    {
      "QualifierName": [
        "diagnosis",
        "virology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Drug Repositioning"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Host-Pathogen Interactions"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "drug effects",
        "pathogenicity"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Treatment Outcome"
    },
    {
      "QualifierName": [],
      "DescriptorName": "COVID-19 Drug Treatment"
    }
  ],
  "CoiStatement": "The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."
}